Recent Advances in the Treatment of Breast Cancer
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: closed (20 December 2021) | Viewed by 2783
Special Issue Editor
Interests: cancer biology; cancer biomarkers; clinical oncology; cell culture; immunohistochemistry; tumor markers; breast cancer; colorectal cancer; chemotherapy; oncology
Special Issue Information
Dear Colleagues,
Breast cancer is acknowledged as an international priority in healthcare. It is currently the most common cancer in women worldwide, with a continuous increase in incidence.
In recent years, cancer research has allowed us to introduce new systemic treatments into clinical practice. Nonetheless, the constant need to improve the therapeutic approach to this disease remains a target to be pursued daily in research activity.
The aim of this Special Issue is to underline the evolution of the treatment of early and advanced breast cancer through reviews of the scientific literature or meta-analyses. At the same time, this Special Issue is aimed at original papers with an exploratory nature investigating new and original therapeutic pathways.
Dr. Armando Orlandi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- target therapy
- predictive factors
- prognostic factors
- hormonal therapy
- neoadjuvant
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.